NCT01718418

Brief Summary

The purpose of the study is to evaluate food factors related to colonically derived regulation of glucose metabolism (and related parameters) and satiety using a semi-acute meal study in healthy subjects as experimental model.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at P25-P50 for early_phase_1 obesity

Timeline
Completed

Started Sep 2012

Shorter than P25 for early_phase_1 obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 9, 2012

Completed
22 days until next milestone

First Posted

Study publicly available on registry

October 31, 2012

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

May 8, 2013

Status Verified

May 1, 2013

Enrollment Period

3 months

First QC Date

October 9, 2012

Last Update Submit

May 7, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Differences in concentration of risk markers in blood, measured post-prandial after a breakfast meal.

    Variables (blood glucose, insulin, incretin, inflammatory markers, markers of colonic fermentation) are measured after two-weeks ingestion of test products. The experimental day is terminated after a lunch meal.

    Post-prandially after breakfast, 0-210 min

Secondary Outcomes (3)

  • voluntary energy intake

    Post-prandially after breakfast, 0-210 min

  • Subjective satiety

    post-prandially after breakfast, 0-210 min

  • Differences in gut microbiota

    Faecal samples are collected after 14 days intake of test- and reference product

Study Arms (3)

+ ind.CHO + prebiotics

EXPERIMENTAL

test meal: intrinsic indigestible carbohydrates in combination with a combined probiotic supplement.

Other: test meal

+ ind.CHO - prebiotics

EXPERIMENTAL

test meal: intrinsic indigestible carbohydrates in combination with placebo probiotic supplement.

Other: test meal

- ind.CHO - prebiotics

EXPERIMENTAL

reference: no ind. carbohydrates and no probiotic supplement

Other: reference

Interventions

+ ind.CHO + prebiotics+ ind.CHO - prebiotics
- ind.CHO - prebiotics

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normal fasting blood glucose, BMI 19-25 kg/m2, for women: hormon based contraceptives

You may not qualify if:

  • gastrointestinal diseases or food allergies e.g. lactose-, gluten intolerance, metabolic disorders e.g. diabetes, tobacco/snuff users. Antibiotic or probiotic usage within two weeks, and during the study. Vegetarians

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Applied Nutrition and Food Chemistry, Lund University

Lund, SE-221 00, Sweden

Location

Related Publications (1)

  • Nilsson A, Johansson-Boll E, Sandberg J, Bjorck I. Gut microbiota mediated benefits of barley kernel products on metabolism, gut hormones, and inflammatory markers as affected by co-ingestion of commercially available probiotics: a randomized controlled study in healthy subjects. Clin Nutr ESPEN. 2016 Oct;15:49-56. doi: 10.1016/j.clnesp.2016.06.006. Epub 2016 Jul 2.

MeSH Terms

Conditions

ObesityMetabolic Syndrome

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Officials

  • Anne Nilsson, PhD

    Lund University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc, post-graduate student

Study Record Dates

First Submitted

October 9, 2012

First Posted

October 31, 2012

Study Start

September 1, 2012

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

May 8, 2013

Record last verified: 2013-05

Locations